Targeted retroviral infection of tumor cells by receptor cooperation

Journal of Virology

Volumn 77, Issue 4, 2003, Pages 2753-2756

  Martin, Francisco ^a,e   Chowdhury, Simon ^a   Neil, Stuart J ^a   Chester, Kerry A ^b   Cosset, Francois Loic ^c   Collins, Mary K ^a,d  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c University Lyon i   (France)

^d Windeyer Institute   (United Kingdom)

^e HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROLINE; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; SPACER DNA; TUMOR ANTIGEN; VIRUS PROTEIN; VIRUS RECEPTOR;

ARTICLE; CANCER CELL; CELL LINE; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; MURINE LEUKEMIA VIRUS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; RECEPTOR BINDING; RETROVIRUS; RETROVIRUS INFECTION; TARGET CELL;

ANTIBODIES, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; GENETIC VECTORS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; MEMBRANE GLYCOPROTEINS; MOLONEY MURINE LEUKEMIA VIRUS; RECEPTORS, VIRUS; TUMOR CELLS, CULTURED;

EID: 0037320189     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.4.2753-2756.2003     Document Type: Article

References (26)

1. Andersen, K. B. 1994. A domain of murine retrovirus surface protein gp70 mediates cell fusion, as shown in a novel SC-1 cell fusion system. J. Virol. 68:3175-3182.
2. Baer, J. C., A. A. Freeman, E. S. Newlands, A. J. Watson, J. A. Rafferty, and G. P. Margison. 1993. Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells. Br. J. Cancer 67:1299-1302.
3. Barnett, A. L., and J. M. Cunningham. 2001. Receptor binding transforms the surface subunit of the mammalian C-type retrovirus envelope protein from an inhibitor to an activator of fusion. J. Virol. 75:9096-9105.
4. Benchimol, S., A. Fuks, S. Jothy, N. Beauchemin, K. Shirota, and C. P. Stanners. 1989. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57:327-334.
5. Chadwick, M. P., F. J. Morling, F. L. Cosset, and S. J. Russell. 1999. Modification of retroviral tropism by display of IGF-I. J. Mol. Biol. 285:485-494.
6. Chester, K. A., R. H. Begent, L. Robson, P. Keep, R. B. Pedley, J. A. Boden, G. Boxer, A. Green, G. Winter, O. Cochet, et al. 1994. Phage libraries for generation of clinically useful antibodies. Lancet 343:455-456.
7. Cosset, F. L., F. J. Morling, Y. Takeuchi, R. A. Weiss, M. K. Collins, and S. J. Russell. 1995. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J. Virol. 69:6314-6322.
8. Cosset, F. L., Y. Takeuchi, J. L. Battini, R. A. Weiss, and M. K. Collins. 1995. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69:7430-7436.
9. Fielding, A. K., M. Maurice, F. J. Morling, F. L. Cosset, and S. J. Russell. 1998. Inverse targeting of retroviral vectors: selective gene transfer in a mixed population of hematopoietic and nonhematopoietic cells. Blood 91:1802-1809.
10. Gordon, E. M., Z. H. Chen, L. Liu, M. Whitley, D. Wei, S. Groshen, D. R. Hinton, W. F. Anderson, R. W. Beart, Jr., and F. L. Hall. 2001. Systemic administration of a matrix-targeted retroviral vector is efficacious for cancer gene therapy in mice. Hum. Gene Ther. 12:193-204.
11. Jobbagy, Z., S. Garfield, L. Baptiste, M. V. Eiden, and W. B. Anderson. 2000. Subcellular redistribution of Pit-2 P(i) transporter/amphotropic leukemia virus (A-MuLV) receptor in A-MuLV-infected NIH 3T3 fibroblasts: involvement in superinfection interference. J. Virol. 74:2847-2854.
12. Khare, P. D., L. Shao-Xi, M. Kuroki, Y. Hirose, F. Arakawa, K. Nakamura, Y. Tomita, and M. Kuroki. 2001. Specifically targeted killing of CEA-expressing cells by a retroviral vector displaying single-chain variable fragmented antibody to CEA and carrying the gene for inducible nitric oxide synthase. Cancer Res. 61:370-375.
13. Konishi, H., T. Ochiya, K. A. Chester, R. H. Begent, T. Muto, T. Sugimura, and M. Terada. 1998. Targeting strategy for gene delivery to carcinoembryonic antigen-producing cancer cells by retrovirus displaying a single-chain variable fragment antibody. Hum. Gene Ther. 9:235-248.
14. Kupsch, J. M., N. Tidman, J. A. Bishop, I. McKay, I. Leigh, and J. S. Crowe. 1995. Generation and selection of monoclonal antibodies, single-chain Fv and antibody fusion phage specific for human melanoma-associated antigens. Melanoma Res. 5:403-411.
15. Lavillette, D., M. Maurice, C. Roche, S. J. Russell, M. Sitbon, and F. L. Cosset. 1998. A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes. J. Virol. 72:9955-9965.
16. Martin, F., S. Chowdhury, S. Nell, N. Phillipps, and M. K. Collins. 2002. Envelope-targeted retrovirus vectors transduce melanoma xenografts but not spleen or liver. Mol. Ther. 5:269-274.
17. Martin, F., S. Neil, J. Kupsch, M. Maurice, F. Cosset, and M. Collins. 1999. Retrovirus targeting by tropism restriction to melanoma cells. J. Virol. 73:6923-6929.
18. Natali, P. G., K. Imai, B. S. Wilson, A. Bigotti, R. Cavaliere, M. A. Pellegrino, and S. Ferrone. 1981. Structural properties and tissue distribution of the antigen recognized by the monoclonal antibody 653.40S to human melanoma cells. J. Natl. Cancer Inst. 67:591-601.
19. Nilson, B. H., F. J. Morling, F. L. Cosset, and S. J. Russell. 1996. Targeting of retroviral vectors through protease-substrate interactions. Gene Ther. 3:280-286.
20. Palmer, K., J. Moore, M. Everard, J. D. Harris, S. Rodgers, R. C. Rees, A. K. Murray, R. Mascari, J. Kirkwood, P. G. Riches, C. Fisher, J. M. Thomas, M. Harries, S. R. Johnston, M. K. Collins, and M. E. Gore. 1999. Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma. Hum. Gene Ther. 10:1261-1268.
21. Peng, K. W., L. Pham, H. Ye, R. Zufferey, D. Trono, F. L. Cosset, and S. J. Russell. 2001. Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors. Gene Ther. 8:1456-1463.
22. Peng, K. W., R. Vile, F. L. Cosset, and S. Russell. 1999. Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors. Gene Ther. 6:1552-1557.
23. Takeuchi, Y., F. L. Cosset, P. J. Lachmann, H. Okada, R. A. Weiss, and M. K. Collins. 1994. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J. Virol. 68:8001-8007.
24. Valsesia-Wittmann, S. 2001. Role of chimeric murine leukemia virus env β-turn polyproline spacers in receptor cooperation. J. Virol. 75:8478-8486.
25. Valsesia-Wittmann, S., F. J. Morling, T. Hatziioannou, S. J. Russell, and F. L. Cosset. 1997. Receptor co-operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding. EMBO J. 16:1214-1223.
26. Zavorotinskaya, T., and L. M. Albritton. 2001. Two point mutations increase targeted transduction and stabilize vector association of a modified retroviral envelope protein. Mol. Ther. 3:323-328.